2m 2m 2m 2m 2m 2m 2m
Grace Therap (GRCE)
NASDAQ
$2.20-$0.02 (-1.08%)
Price as of Sep 11, 2026 7:30 PM EDT- $46.7MMarket Cap
- -29.52%1-Year Change
- BiotechnologyIndustry
Grace Therap (GRCE)
$2.20-$0.02 (-1.08%)
GRCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.22 | ||
Change | -$0.04 (-1.77%) | ||
Open | $2.29 | ||
High | $2.46 | ||
Low | $2.20 | ||
Previous Close | $2.26 | ||
Volume | 716,523 | ||
30-Day Average Volume | 165,829 | ||
1-Week Change | 5.71% | ||
1-Month Change | 4.72% | ||
1-Year Change | -29.52% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.0M | ||
Total Assets | $50.1M | ||
Market Cap | $46.7M | ||
Enterprise Value | $24.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$15.8M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$15.8M | ||
EBITDA | -$15.8M | ||
Net Working Capital | $13.1M | ||
EPS | -$0.91 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue